MedTrace Logo

The Effects of an L-histidine-Based Supplement, Eczema Topical, and Unscented Soap on Children With Eczema

NCT07670676 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-06-26

No results posted yet for this study

Summary

The purpose of this study is to examine the effects of 2 dietary supplements containing the amino acid, L-histidine, alongside a plant-biotech topical product, and an unscented bar soap on 2 age groups of children with mild to moderate atopic dermatitis (group 1: ages 1-3 years, group 2: 4-12 years).

Conditions

  • Atopic Dermatitis (Eczema)

Interventions

OTHER

Powder Supplement + Topical Oil + Unscented Soap

The intervention includes 3 products: 1. A powder dietary supplement containing 0.8g of L-histidine to be mixed with food or liquid of choice. 2. A topical oil to be used at least twice daily and as often as needed on the face and body. 3. An unscented soap to be used twice daily (in the morning and evening) on the face and body, in replacement of the usual cleansing product.

OTHER

Gummy Supplement + Topical Lotion + Unscented Soap

The intervention includes 3 products: 1. Gummy supplements containing 0.8g of L-histidine. 2. A topical lotion to be used at least twice daily and as often as needed on the face and body. 3. An unscented soap to be used twice daily (in the morning and evening) on the face and body, in replacement of the usual cleansing product.

Sponsors & Collaborators

  • Codex Labs Corporation

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-19
Primary Completion
2026-03-31
Completion
2026-03-31

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07670676 on ClinicalTrials.gov